MFDS — authorised 1 February 2013
- Marketing authorisation holder: HYPERION THERAP INC
- Status: likely_approved
🇰🇷 Ravicti in South Korea
MFDS authorised Ravicti on 1 February 2013
Marketing authorisation
Ravicti in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in South Korea
Frequently asked questions
Is Ravicti approved in South Korea?
Yes. MFDS authorised it on 1 February 2013.
Who is the marketing authorisation holder for Ravicti in South Korea?
HYPERION THERAP INC holds the South Korean marketing authorisation.